Anavex Life Sciences
AVXL
AVXL
139 hedge funds and large institutions have $310M invested in Anavex Life Sciences in 2022 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 55 increasing their positions, 30 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
19% less capital invested
Capital invested by funds: $383M → $310M (-$73.4M)
28% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 32
Holders
139
Holding in Top 10
1
Calls
$20.8M
Puts
$9.48M
Top Buyers
| 1 | +$21.4M | |
| 2 | +$4.78M | |
| 3 | +$3.6M | |
| 4 |
PC
Pier Capital
Stamford,
Connecticut
|
+$2.61M |
| 5 |
KCM
Knoll Capital Management
Miami,
Florida
|
+$2.59M |
Top Sellers
| 1 | -$4.98M | |
| 2 | -$3.24M | |
| 3 | -$1.74M | |
| 4 |
Vontobel Holding
Zurich,
Switzerland
|
-$1.04M |
| 5 |
Barclays
London,
United Kingdom
|
-$891K |